Phase II Trial of Pembrolizumab after High-Dose Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia
高剂量阿糖胞苷治疗复发/难治性急性髓系白血病后进行派姆单抗 II 期临床试验
期刊:Blood Cancer Discovery
影响因子:11.5
doi:10.1158/2643-3230.BCD-21-0070
Joshua F Zeidner, Benjamin G Vincent, Anastasia Ivanova, Dominic Moore, Karen P McKinnon, Alec D Wilkinson, Rupkatha Mukhopadhyay, Francesco Mazziotta, Hanna A Knaus, Matthew C Foster, Catherine C Coombs, Katarzyna Jamieson, Hendrik Van Deventer, Jonathan A Webster, Gabrielle T Prince, Amy E DeZern,